These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35733781)

  • 1. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
    Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
    Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
    Zhou B; Wei L; Qin J
    Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating US-guided FNAB, BRAF
    Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting factors of central lymph node metastasis and BRAF
    Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
    World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating BRAF
    Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
    BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
    Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
    Zhou B; Qin J
    Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor.
    Chen Y; Zhao S; Zhang Z; Chen Z; Jiang B; An M; Shang M; Wu X; Zhang X; Chen B
    Front Endocrinol (Lausanne); 2024; 15():1429382. PubMed ID: 39363900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
    Li X; Zhang H; Zhou Y; Cheng R
    World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
    Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
    Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation.
    Chen H; Pan WK; Ren SY; Zhou YL
    Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
    Gao X; Luo W; He L; Cheng J; Yang L
    Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification.
    Wu WX; Qi GF; Feng JW; Ye J; Hong LZ; Wang F; Liu SY; Jiang Y
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2511-2523. PubMed ID: 36622416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.
    Lei Y; Zhao X; Feng Y; He D; Hu D; Min Y
    Cancer Control; 2023; 30():10732748231155701. PubMed ID: 36744396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
    Jianming L; Jibin L; Linxue Q
    Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
    Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
    Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
    Tang T; Li J; Zheng L; Zhang L; Shi J
    Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.